CASP8 and neuroblastoma: The hypermethylation of Caspase-8 promoter and the subsequent loss of Caspase-8 expression have been reported in medulloblastoma [17,18], neuroblastoma [19], cervical cancer [20], breast cancer [21] and glioblastoma [22].